[A large case load of patients with dyslipidemia: effects of treatment with deae-dextran].
The authors report the results of an open trial in 859 dyslipidemic patients, performed with the cooperation of general practitioners, treated with isocaloric diet and daily doses of 3 g deae-dextran for 3 months. Deae-dextran was effective in reducing cholesterol and triglyceride blood levels and in controlling body weight. The drug was very well tolerated and no significant side effects were registered during treatment with deae-dextran.
Barone
A
A
Divisione di Medicina, Ospedale Unificato di Fano-Mondolfo.
Frausini
G
G
Ansuini
R
R
Francolini
G
G
Canestrari
M
M
Ultimare
R
R
Pupita
F
F
D000328:Adult; D000368:Aged; D003637:DEAE-Dextran / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D015228:Hypertriglyceridemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D003911:Dextrans; D003637:DEAE-Dextran
Studio su un'ampia casistica di soggetti dislipidemici: effetti del trattamento con il deae-destrano.